[1] |
EKE P I, DYE B A, WEI L, et al. Prevalence of periodontitis in adults in the United States:2009 and 2010[J]. J Dent Res, 2012, 91(10):914-920.
DOI
URL
|
[2] |
MICHALEK I M, LORING B, JOHN S M. A systematic review of worldwide epidemiology of psoriasis[J]. J Eur Acad Dermatol Venereol, 2017, 31(2):205-212.
DOI
URL
|
[3] |
FORD E S, GILES W H, DIETZ W H. Prevalence of the metabolic syndrome among US adults:findings from the third National Health and Nutrition Examination Survey[J]. JAMA, 2002, 287(3):356-359.
DOI
URL
|
[4] |
GOBIN R, TIAN D, LIU Q, et al. Periodontal diseases and the risk of metabolic syndrome:an updated systematic review and meta-analysis[J]. Front Endocrinol(Lausanne), 2020, 11:336.
|
[5] |
ARMSTRONG A W, HARSKAMP C T, ARMSTRONG E J. Psoriasis and metabolic syndrome:a systematic review and meta-analysis of observational studies[J]. J Am Acad Dermatol, 2013, 68(4):654-662.
DOI
URL
|
[6] |
RODRÍGUEZ-ZÚÑIGA M J M, GARCÍA-PERDOMO H A. Systematic review and meta-analysis of the association between psoriasis and metabolic syndrome[J]. J Am Acad Dermatol, 2017, 77(4):657-666.e8.
DOI
URL
|
[7] |
中华医学会皮肤性病学分会银屑病专业委员会. 中国银屑病诊疗指南(2018完整版)[J]. 中华皮肤科杂志, 2019, 52(10):667-710.
|
[8] |
PAGE R C, EKE P I. Case definitions for use in population-based surveillance of periodontitis[J]. J Periodontol, 2007, 78(7 Suppl):1387-1399.
DOI
URL
|
[9] |
ARMSTRONG A W, HARSKAMP C T, ARMSTRONG E J. The association between psoriasis and hypertension:a systematic review and meta-analysis of observational studies[J]. J Hypertens, 2013, 31(3):433-442.
DOI
URL
|
[10] |
ARMSTRONG A W, HARSKAMP C T, ARMSTRONG E J. Psoriasis and the risk of diabetes mellitus:a systematic review and meta-analysis[J]. JAMA Dermatol, 2013, 149(1):84-91.
DOI
URL
|
[11] |
SKUDUTYTE-RYSSTAD R, SLEVOLDEN E M, HANSEN B F, et al. Association between moderate to severe psoriasis and periodontitis in a Scandinavian population[J]. BMC Oral Health, 2014, 14:139.
DOI
URL
|
[12] |
UNGPRASERT P, WIJARNPREECHA K, WETTER D A. Periodontitis and risk of psoriasis:a systematic review and meta-analysis[J]. J Eur Acad Dermatol Venereol, 2017, 31(5):857-862.
DOI
URL
|
[13] |
GERDES S, ROSTAMI-YAZDI M, MROWIETZ U. Adipokines and psoriasis[J]. Exp Dermatol, 2011, 20(2):81-87.
DOI
URL
|
[14] |
TORRES T, SELORES M. Does treatment of metabolic syndrome components improve psoriasis? Report of three cases[J]. Eur J Dermatol, 2012, 22(2):270-272.
DOI
URL
|
[15] |
HOLZER M, WOLF P, INZINGER M, et al. Anti-psoriatic therapy recovers high-density lipoprotein composition and function[J]. J Invest Dermatol, 2014, 134(3):635-642.
DOI
URL
|
[16] |
SAITO T, MURAKAMI M, SHIMAZAKI Y, et al. Association between alveolar bone loss and elevated serum C-reactive protein in Japanese men[J]. J Periodontol, 2003, 74(12):1741-1746.
DOI
URL
|
[17] |
LÓPEZ N J, QUINTERO A, CASANOVA P A, et al. Effects of periodontal therapy on systemic markers of inflammation in patients with metabolic syndrome:a controlled clinical trial[J]. J Periodontol, 2012, 83(3):267-278.
DOI
URL
|